Get the Stockscreener App
178.45
0.03%
0.06
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $178.45, with a volume of 548.89K.
It is up +0.03% in the last 24 hours and up +0.12% over the past month.
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
See More
Previous Close:
$178.39
Open:
$178.48
24h Volume:
548.89K
Relative Volume:
0.34
Market Cap:
$9.34B
Revenue:
$1.53B
Net Income/Loss:
$207.70M
P/E Ratio:
-64.34
EPS:
-2.7734
Net Cash Flow:
$193.10M
1W Performance:
-0.01%
1M Performance:
+0.12%
6M Performance:
+21.39%
1Y Performance:
+17.29%
1-Day Range:
$178.25
$178.50
1-Week Range:
$178.25
$178.53
52-Week Range:
$125.94
$179.00
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
178.45 | 9.34B | 1.53B | 207.70M | 193.10M | -2.7734 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-17-25 | Initiated | BofA Securities | Neutral |
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Masimo Corporation (NASDAQ:MASI) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat
MSN Money - MSN
Denon Receiver: Premium Audio Powerhouse Faces Streaming Market Shifts - AD HOC NEWS
13,196 Shares in Masimo Corporation $MASI Bought by Lecap Asset Management Ltd. - MarketBeat
Masimo's Appeal Rejection, M5 Chip Push, China Smartphone Growth, Foldable iPhone: This Week In Appleverse - Benzinga
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Masimo Corporation $MASI - MarketBeat
Apple Scores Key Win As Trade Commission Rejects Masimo's Bid To Reinstate Apple Watch Import Ban - Benzinga
Apple secures a win as US trade tribunal rejects Masimo’s bid for new watch ban - Investing.com
Apple secures a win as US trade tribunal rejects Masimo’s bid for new watch ban By Investing.com - Investing.com South Africa
Apple Clears Major Legal Hurdle After U.S. Trade Tribunal Shuts Down Masimo’s Latest Watch Ban Attempt - Stocktwits
Apple defeats bid for new Apple Watch import ban at US trade tribunal - Reuters
Masimo Corporation (NASDAQ:MASI) Short Interest Update - MarketBeat
Masimo (MASI) Secures $100M Contract for Patient Monitoring Equi - GuruFocus
Masimo (MASI) Secures $100M Contract Modification for Patient Mo - GuruFocus
Denon Receiver: Premium Audio Power Faces Streaming and Smart Home Shifts - AD HOC NEWS
Denon Receiver: Between Audio Innovation and Ownership Shifts, Market Position Strengthens - AD HOC NEWS
Massachusetts Financial Services Co. MA Boosts Stock Position in Masimo Corporation $MASI - MarketBeat
Published on: 2026-04-12 06:39:28 - baoquankhu1.vn
Masimo Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
Masimo Buyout By Danaher Faces Shareholder Scrutiny On Deal Value - Yahoo Finance
Market news - investments.halifax.co.uk
Masimo stock price target raised to $180 by Jefferies on Danaher deal - Investing.com UK
31,641 Shares in Masimo Corporation $MASI Acquired by Tudor Investment Corp ET AL - MarketBeat
Masimo Corp Stock Historical Valuations | BSP:M2AS34 - GuruFocus
Masimo Corp Stock Intrinsic Values | BSP:M2AS34 - GuruFocus
Masimo Corp (BSP:M2AS34) Competitors 2026 - GuruFocus
Masimo Corp (BSP:M2AS34) Valuation: Fairly Valued - GuruFocus
Masimo Corp (BSP:M2AS34) Dividend - GuruFocus
Masimo Corp (BSP:M2AS34) Stock Price & 30 Year Financial Data - GuruFocus
Masimo Corp Stock Operating Data - GuruFocus
Masimo Corp Stock Baskets | BSP:M2AS34 - GuruFocus
Masimo Corp Stock Warning Signs | BSP:M2AS34 - GuruFocus
Masimo Corp (BSP:M2AS34) Stock Price, Trades & News - GuruFocus
Masimo Corp (BSP:M2AS34) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Masimo Corp (BSP:M2AS34) Stock News, Headlines & Updates - GuruFocus
Masimo Corp (BSP:M2AS34) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Who's Buying or Selling Masimo Corp (BSP:M2AS34) Stock Today? - GuruFocus
Wealth Enhancement Advisory Services LLC Raises Stake in Masimo Corporation $MASI - MarketBeat
SG Americas Securities LLC Increases Stock Position in Masimo Corporation $MASI - MarketBeat
Masimo Corporation (MASI) stock price, news, quote and history - Yahoo Finance UK
Masimo Corporation (MASI) Stock forecasts - Yahoo Finance UK
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN - Benzinga
Masimo (MASI) agrees to $180 cash takeover by Danaher; vote set May 1, 2026 - Stock Titan
Quinn Emanuel disqualified in Masimo board dispute - Daily Journal
Quinn Emanuel Disqualified from Masimo Board Fight with Founder - National Today
Quinn Emanuel Disqualified From Masimo Board Fight With Founder - Bloomberg Law News
Masimo Corp Stock: Innovative Medical Tech Leader with Strong Growth Potential for North American In - AD HOC NEWS
Assenagon Asset Management S.A. Grows Stock Holdings in Masimo Corporation $MASI - MarketBeat
Masimo Corp Stock Faces Uncertainty Amid Analyst Downgrade and Pending Danaher Acquisition Deal - AD HOC NEWS
Danaher to Acquire Masimo Diagnostics in $9.9B Deal - USA Herald
The Vanguard Group discloses 0 shares in Masimo Corp (NASDAQ: MASI) - Stock Titan
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):